US86882C2044 - Common Stock
SURGALIGN HOLDINGS INC
NASDAQ:SRGA (6/30/2023, 7:00:01 PM)
After market: 0.1235 -0.06 (-32.48%)0.1829
-0.09 (-32.98%)
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 217 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology platform, is designed to automatically recognize, identify, and segment patient anatomy to autonomously assist the surgeon throughout the surgical procedure. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. Its market and sell products to hospitals, ambulatory surgery centers, and healthcare providers in the United States.
SURGALIGN HOLDINGS INC
520 Lake Cook Rd Ste 315
Deerfield ILLINOIS 60015
P: 18773436832.0
CEO: Terry M. Rich
Employees: 217
Website: https://www.surgalign.com/
Trxade Health (MEDS) stock is falling on Tuesday after the company announced it would undergo a merger with Superlatus.
Lordstown Motors (RIDE) stock is falling hard on Tuesday after the troubled electric vehicle (EV) company filed for bankruptcy.
View (VIEW) stock is on the rise Tuesday with heavy trading despite a lack of news from the smart building products company.
Surgalign Holdings (SRGA) stock is on the rise Tuesday after the company recently received a delisting notice alongside a bankruptcy filing.
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on Tuesday morning!
MoonLake Immunotherapeutics (MLTX) stock is taking off on Monday after reporting positive results from a Phase 2 clinical trial.
Here you can normally see the latest stock twits on SRGA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: